Articles by
-
Nonstimulant Approved for Adult ADHD
The FDA approved the use of viloxazine (Qelbree) extended-release capsules for adults 18 years of age and older…
-
Vaccination Coverage in School Children Fell During the Pandemic
During the 2021-22 school year, vaccination coverage among kindergartners nationwide was lower than during the 2019-20 school year,…
-
FDA Warns of Risks Associated With Noninvasive Prenatal Screening Tests
The FDA is warning the public of the risk of false results, inappropriate use, and inappropriate interpretation of…
-
PreHevbrio Hepatitis B Vaccine Now Available for Adult Hepatitis B Vaccination
VBI’s hepatitis B vaccine (recombinant) (PreHevbrio) is now available for the prevention of infection caused by all known…
-
WHO Panel Concludes That a Single Dose of HPV Vaccine Is Protective
The World Health Organization’s Strategic Advisory Group of Experts on Immunization (SAGE) announced that there is enough evidence…
-
CDC Warns of Severe Hepatitis and Adenovirus Infections in Children
The US Centers for Disease Control and Prevention (CDC) issued a Health Alert Network Health Advisory to notify…
-
CDC: STDs Continued to Increase During First Year of COVID-19 Pandemic
The US Centers for Disease Control and Prevention (CDC) announced that sexually transmitted diseases (STDs) continued to increase…
-
FDA Approves First Sublingual Medication for Agitation in Serious Mental Illness
The FDA approved dexmedetomidine (Igalmi) sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar…
-
New York and Kansas Grant Full Practice Authority to NPs
Nurse practitioners licensed in New York and Kansas are now fully able to practice independently, joining 24 other…
-
Appropriate Antibiotic Prescribing for Acute Respiratory Infections
In 2020, healthcare providers prescribed 201.9 million antibiotic prescriptions—equivalent to 613 antibiotic prescriptions per 1,000 persons.1 Studies have…
-
FDA Approves New Indication for IL-23 Inhibitor for Adults With Active Psoriatic Arthritis
Risankizumab-rzaa (Skyrizi) is now approved for the treatment of adults with active psoriatic arthritis. It is the only…
-
Carbidopa/Levodopa Fractional Tablet Now Available for Parkinson’s Disease
A carbidopa/levodopa tablet formulation (Dhivy) designed to facilitate dose adjustment is now available for the treatment of Parkinson’s…
Join our email list
Get new course alerts, newsletters and more delivered directly to your inbox
By providing my personal information, including phone number, I consent to (1) receive email messages with information and offers, autodialed calls, texts, and prerecorded messages from FHEA, including current and possible future services, customer service and billing; and (2) FHEA’s Privacy Policy and Terms and Conditions. I understand that my consent is not required to purchase, and that cancellation of purchase does not automatically revoke this consent.